View in EDS HTML Full Text PDF Full Text

Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics.

Saved in:
Bibliographic Details
Title: Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics.
Authors: Marković, Srđan1,2 (AUTHOR), Kralj, Đorđe1 (AUTHOR), Svorcan, Petar1,2 (AUTHOR), Knežević Ivanovski, Tamara1 (AUTHOR), Odanović, Olga1 (AUTHOR), Obradović, Sanja3 (AUTHOR), Homšek, Ana4 (AUTHOR), Jovanović, Marija4 (AUTHOR), Savić, Rada5 (AUTHOR), Vučićević, Katarina M.4 (AUTHOR) katarina.vucicevic@pharmacy.bg.ac.rs
Source: Pharmaceutics. Dec2024, Vol. 16 Issue 12, p1629. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19994923
DOI:10.3390/pharmaceutics16121629